These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12193654)

  • 1. A linear lattice model for polyglutamine in CAG-expansion diseases.
    Bennett MJ; Huey-Tubman KE; Herr AB; West AP; Ross SA; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11634-9. PubMed ID: 12193654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.
    Chen S; Berthelier V; Yang W; Wetzel R
    J Mol Biol; 2001 Aug; 311(1):173-82. PubMed ID: 11469866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-PolyQ Antibodies Recognize a Short PolyQ Stretch in Both Normal and Mutant Huntingtin Exon 1.
    Owens GE; New DM; West AP; Bjorkman PJ
    J Mol Biol; 2015 Jul; 427(15):2507-2519. PubMed ID: 26047735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model.
    Li P; Huey-Tubman KE; Gao T; Li X; West AP; Bennett MJ; Bjorkman PJ
    Nat Struct Mol Biol; 2007 May; 14(5):381-7. PubMed ID: 17450152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.
    Bett JS; Goellner GM; Woodman B; Pratt G; Rechsteiner M; Bates GP
    Hum Mol Genet; 2006 Jan; 15(1):33-44. PubMed ID: 16311253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation.
    Chen S; Ferrone FA; Wetzel R
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11884-9. PubMed ID: 12186976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous formation of annular structures observed in molecular dynamics simulations of polyglutamine peptides.
    Marchut AJ; Hall CK
    Comput Biol Chem; 2006 Jun; 30(3):215-8. PubMed ID: 16678490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells.
    Onodera O; Burke JR; Miller SE; Hester S; Tsuji S; Roses AD; Strittmatter WJ
    Biochem Biophys Res Commun; 1997 Sep; 238(2):599-605. PubMed ID: 9299559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations.
    Marchut AJ; Hall CK
    Proteins; 2007 Jan; 66(1):96-109. PubMed ID: 17068817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligoproline effects on polyglutamine conformation and aggregation.
    Bhattacharyya A; Thakur AK; Chellgren VM; Thiagarajan G; Williams AD; Chellgren BW; Creamer TP; Wetzel R
    J Mol Biol; 2006 Jan; 355(3):524-35. PubMed ID: 16321399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome degrades soluble expanded polyglutamine completely and efficiently.
    Michalik A; Van Broeckhoven C
    Neurobiol Dis; 2004 Jun; 16(1):202-11. PubMed ID: 15207277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Design and synthesis of peptides capable of specific binding to DNA].
    Grokhovskiĭ SL; Surovaia AN; Sidorova NIu; Votavova H; Sponar J
    Mol Biol (Mosk); 1988; 22(5):1315-34. PubMed ID: 2851717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stable G-quartet binds to a huntingtin protein fragment containing expanded polyglutamine tracks.
    Yerkes S; Vesenka J; Kmiec EB
    J Neurosci Res; 2010 Feb; 88(2):335-45. PubMed ID: 19705452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra- and intermolecular beta-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases.
    Tanaka M; Morishima I; Akagi T; Hashikawa T; Nukina N
    J Biol Chem; 2001 Nov; 276(48):45470-5. PubMed ID: 11584007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear and extended: a common polyglutamine conformation recognized by the three antibodies MW1, 1C2 and 3B5H10.
    Klein FA; Zeder-Lutz G; Cousido-Siah A; Mitschler A; Katz A; Eberling P; Mandel JL; Podjarny A; Trottier Y
    Hum Mol Genet; 2013 Oct; 22(20):4215-23. PubMed ID: 23777629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure prediction of polyglutamine disease proteins: comparison of methods.
    Wen J; Scoles DR; Facelli JC
    BMC Bioinformatics; 2014; 15 Suppl 7(Suppl 7):S11. PubMed ID: 25080018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation.
    Walters RH; Murphy RM
    J Mol Biol; 2009 Nov; 393(4):978-92. PubMed ID: 19699209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides.
    Altschuler EL; Hud NV; Mazrimas JA; Rupp B
    J Pept Res; 1997 Jul; 50(1):73-5. PubMed ID: 9273890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of expanded polyglutamine-domain proteins in Escherichia coli.
    Onodera O; Roses AD; Tsuji S; Vance JM; Strittmatter WJ; Burke JR
    FEBS Lett; 1996 Dec; 399(1-2):135-9. PubMed ID: 8980137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.